Transfusion Guidelines for Major Hemorrhage Major hemorrhage is an emergency with significant morbidity and mortality. The British Society for Haematology (BSH) has updated transfusion guidelines… June 22, 2022
Donor-Recipient Sex and RBC Transfusion Outcomes Deferring plasma from multiparous females has dramatically reduced the incidence of antibody-mediated transfusion-related acute lung injury (TRALI). Some observational studies… June 14, 2022
Anti-CD19 CAR-T Cells as First-Line Therapy for High-Risk Large B-Cell Lymphoma Large-B-cell lymphoma (LBCL) is one of the most common types of non-Hodgkin lymphoma, and many patients do not respond well… June 7, 2022
Updated FDA Guidance to Reduce Risk of Transmission of Creutzfeldt-Jakob Disease The U.S. Food and Drug Administration (FDA) has issued updated guidance to reduce the transfusion-related transmission risk of Creutzfeldt-Jakob disease… June 1, 2022
Genomic Profiles Associated with CAR T-Cell Therapy Efficacy Chimeric antigen receptor (CAR) T-cell therapy is a promising therapy used to treat hematological cancers by targeting a specific antigen. … May 24, 2022
Risk Factors for Allergic Transfusion Reactions in Pediatric Patients Allergic transfusion reactions (ATRs) are common and can range from mild to severe. Younger age, hematological/oncological disease, increasing number of… May 17, 2022
Target Trial Emulation Using Real World Data Suggest Older RBCs May Increase Mortality Data from many randomized clinical trials (RCTs) have not found an impact of storage time of red blood cells on… May 11, 2022
Tranexamic Acid in Noncardiac Surgeries Large randomized clinical trials have shown that tranexamic acid safely reduces bleeding in patients undergoing cardiac surgery or cesarean sections,… May 3, 2022
